Wolverine Asset Management LLC bought a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 92,968 shares of the pharmacy operator's stock, valued at approximately $833,000.
Other hedge funds have also recently modified their holdings of the company. Avantax Advisory Services Inc. boosted its stake in Walgreens Boots Alliance by 26.2% during the 1st quarter. Avantax Advisory Services Inc. now owns 54,933 shares of the pharmacy operator's stock worth $1,191,000 after purchasing an additional 11,389 shares during the last quarter. Cozad Asset Management Inc. acquired a new position in Walgreens Boots Alliance during the first quarter worth about $325,000. Entropy Technologies LP purchased a new stake in Walgreens Boots Alliance during the 1st quarter valued at about $509,000. Koshinski Asset Management Inc. acquired a new stake in Walgreens Boots Alliance in the 1st quarter valued at about $223,000. Finally, State Board of Administration of Florida Retirement System lifted its stake in Walgreens Boots Alliance by 2.7% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 832,035 shares of the pharmacy operator's stock worth $18,047,000 after purchasing an additional 21,723 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company's stock.
Walgreens Boots Alliance Trading Up 0.2 %
Shares of NASDAQ WBA traded up $0.02 during trading on Wednesday, reaching $9.03. The stock had a trading volume of 16,744,842 shares, compared to its average volume of 17,341,381. The company has a market cap of $7.81 billion, a P/E ratio of -0.90, a PEG ratio of 1.18 and a beta of 0.69. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.22 and a fifty-two week high of $27.05. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The business's 50-day moving average price is $9.18 and its 200-day moving average price is $12.01.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. During the same period in the prior year, the firm earned $0.67 EPS. The firm's revenue for the quarter was up 5.9% on a year-over-year basis. On average, equities research analysts predict that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current fiscal year.
Walgreens Boots Alliance Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 11.07%. The ex-dividend date of this dividend is Monday, November 18th. Walgreens Boots Alliance's dividend payout ratio is currently -9.99%.
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on WBA. JPMorgan Chase & Co. dropped their price target on Walgreens Boots Alliance from $20.00 to $15.00 and set an "overweight" rating for the company in a research report on Friday, August 30th. TD Cowen dropped their target price on Walgreens Boots Alliance from $16.00 to $14.00 and set a "buy" rating for the company in a report on Tuesday, October 22nd. UBS Group lifted their price target on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a "neutral" rating in a report on Thursday, October 17th. Morgan Stanley lowered their price target on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an "underweight" rating on the stock in a research report on Friday, October 11th. Finally, Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a "hold" rating for the company in a research report on Monday, October 7th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, Walgreens Boots Alliance has a consensus rating of "Hold" and a consensus target price of $12.88.
View Our Latest Stock Report on WBA
About Walgreens Boots Alliance
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Read More
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.